Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Polymorphisms in the apoptotic pathway gene BCL-2 and survival in small cell lung cancer.

Knoefel LF, Werle-Schneider G, Dally H, Müller PJ, Edler L, Bartsch H, Tuengerthal S, Heussel CP, Reinmuth N, Thomas M, Risch A.

J Thorac Oncol. 2011 Jan;6(1):183-9. doi: 10.1097/JTO.0b013e3181f8a20e.

2.

Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis.

Scherf DB, Dally H, Müller P, Werle-Schneider G, Jäger B, Edler L, Tuengerthal S, Fischer JR, Drings P, Bartsch H, Risch A.

Eur Respir J. 2010 Feb;35(2):381-90. doi: 10.1183/09031936.00125608. Epub 2009 Jul 30.

3.

Constitutive mRNA expression of DNA repair-related genes as a biomarker for clinical radio-resistance: A pilot study in prostate cancer patients receiving radiotherapy.

Hümmerich J, Werle-Schneider G, Popanda O, Celebi O, Chang-Claude J, Kropp S, Mayer C, Debus J, Bartsch H, Schmezer P.

Int J Radiat Biol. 2006 Aug;82(8):593-604.

PMID:
16966187
4.

Gene expression profiles in rat liver slices exposed to hepatocarcinogenic enzyme inducers, peroxisome proliferators, and 17alpha-ethinylestradiol.

Werle-Schneider G, Wölfelschneider A, von Brevern MC, Scheel J, Storck T, Müller D, Glöckner R, Bartsch H, Bartelmann M.

Int J Toxicol. 2006 Sep-Oct;25(5):379-95.

PMID:
16940010
5.

De novo retrotransposition of unbiased sequences in a human breast cancer cell clone.

Werle-Schneider G, von Brevern MC, Sylla BS, Hollstein MC.

Genes Chromosomes Cancer. 1999 Sep;26(1):84-91.

PMID:
10441010
6.

On the origins of tumor mutations in cancer genes: insights from the p53 gene.

Hollstein M, Moeckel G, Hergenhahn M, Spiegelhalder B, Keil M, Werle-Schneider G, Bartsch H, Brickmann J.

Mutat Res. 1998 Sep 20;405(2):145-54. Review. No abstract available.

PMID:
9748548
7.

Development and validation of alternative metabolic systems for mutagenicity testing in short-term assays.

Rueff J, Chiapella C, Chipman JK, Darroudi F, Silva ID, Duverger-van Bogaert M, Fonti E, Glatt HR, Isern P, Laires A, Léonard A, Llagostera M, Mossesso P, Natarajan AT, Palitti F, Rodrigues AS, Schinoppi A, Turchi G, Werle-Schneider G.

Mutat Res. 1996 Jun 12;353(1-2):151-76. Review.

PMID:
8692190
8.

Substance-dependent sex differences in the activation of benzylic alcohols to mutagens by hepatic sulfotransferases of the rat.

Glatt H, Pauly K, Frank H, Seidel A, Oesch F, Harvey RG, Werle-Schneider G.

Carcinogenesis. 1994 Nov;15(11):2605-11.

PMID:
7955113
9.

1-Hydroxymethylpyrene and its sulfuric acid ester: toxicological effects in vitro and in vivo, and metabolic aspects.

Glatt H, Werle-Schneider G, Enders N, Monnerjahn S, Pudil J, Czich A, Seidel A, Schwarz M.

Chem Biol Interact. 1994 Jun;92(1-3):305-19.

PMID:
8033264
10.

Development of hydroxysteroid sulfotransferase-deficient lesions during hepatocarcinogenesis in rats.

Werle-Schneider G, Schwarz M, Glatt H.

Carcinogenesis. 1993 Nov;14(11):2267-70.

PMID:
8242853

Supplemental Content

Loading ...
Support Center